Thiopurine Drugs in the Treatment of Ulcerative Colitis: Identification of a Novel Deleterious Mutation in TPMT
Chronic inflammatory bowel disease (IBD) includes Crohn’s disease and ulcerative colitis. Both are characterized by inflammation of part of the digestive tract lining. Azathioprine (AZA) is a well-known immunosuppressant that has been known for many years for its ability to provide long-term disease...
Main Authors: | Pierre-Olivier Harmand, Jérôme Solassol |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/10/1212 |
Similar Items
-
Establishment of human lymphoma cell lines with different thiopurine S-methyltransferase (TPMT) activities and differential proteome analysis after thiopurine exposure.
by: Misdaq, Misbah
Published: (2013) -
Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response
by: Abaji R, et al.
Published: (2017-05-01) -
Alopecia Universalis Associated with Ulcerative Colitis and The Role of Azathioprine
by: Kyrillus S Shohdy, et al.
Published: (2018-01-01) -
The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn’s Disease
by: Ha C, et al.
Published: (2020-11-01) -
Evaluation of low doses of Azathioprine in reducing relapse and corticosteroid dependence in patients with Ulcerative Colitis
by: Maryam Rezaiee, et al.
Published: (2019-05-01)